March Altus Capital Management LP - Q2 2016 holdings

$12.9 Million is the total value of March Altus Capital Management LP's 8 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 33.3% .

 Value Shares↓ Weighting
ACAD BuyACADIA PHARMACEUTICALS INC$2,685,000
+345.3%
82,723
+283.8%
20.75%
+232.6%
LLY  LILLY ELI & CO$2,111,000
+9.3%
26,8100.0%16.32%
-18.3%
EW BuyEDWARDS LIFESCIENCES CORP$1,856,000
+20.6%
18,611
+6.7%
14.35%
-9.9%
JNJ NewJOHNSON & JOHNSON$1,577,00013,000
+100.0%
12.19%
ALGN BuyALIGN TECHNOLOGY INC$1,395,000
+257.7%
17,319
+222.8%
10.78%
+167.2%
PETX  ARATANA THERAPEUTICS INC$1,381,000
+14.5%
218,5150.0%10.68%
-14.4%
ALXN  ALEXION PHARMACEUTICALS INC$1,004,000
-16.1%
8,5990.0%7.76%
-37.3%
DXCM SellDEXCOM INC$928,000
-28.2%
11,700
-38.6%
7.17%
-46.4%
ATHN ExitATHENAHEALTH INC$0-4,900
-100.0%
-7.04%
REGN ExitREGENERON PHARMACEUTICALS$0-2,291
-100.0%
-8.55%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-07-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC12Q3 201614.4%
LILLY ELI & CO12Q3 201620.0%
ALEXION PHARMACEUTICALS INC11Q3 201615.1%
MALLINCKRODT PUB LTD CO8Q3 20157.0%
UNITED THERAPEUTICS CORP DEL7Q3 201511.7%
REGENERON PHARMACEUTICALS7Q3 201614.6%
UNIVERSAL HLTH SVCS INC7Q2 201512.1%
ZOETIS INC7Q3 20165.2%
INCYTE CORP6Q4 201514.7%
EDWARDS LIFESCIENCES CORP5Q3 201628.5%

View March Altus Capital Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2016-11-07
13F-HR2016-07-27
13F-HR2016-05-12
13F-HR2016-02-16
13F-HR2015-11-16
13F-HR2015-08-14
13F-HR2015-05-15
13F-HR2015-02-17
13F-HR2014-11-14
13F-HR2014-08-14

View March Altus Capital Management LP's complete filings history.

Compare quarters

Export March Altus Capital Management LP's holdings